Object Details
maker
Genentech, Inc.
Description (Brief)
(From box) Dilute prior to use; for intravenous infusion only; single-use vial; discard unused portion
(From insert)
PERJETA is a HER2/neu receptor antagonist indicated in combination with trastuzumab and docetaxel for the treatment of patients with HER2-positive metastatic breast cancer who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.
Location
Currently not on view
Credit Line
Gift of Genentech, Inc.
date made
ca 2013
product expiration date
2014-02
ID Number
2013.0069.09
catalog number
2013.0069.09
accession number
2013.0069
Object Name
pharmaceutical
biological
Physical Description
plastic (overall material)
glass (overall material)
metal (overall material)
cardboard (overall material)
pertuzumab, 420mg/14 mL (overall ingredient)
Measurements
overall: 1 3/4 in x 2 3/4 in x 3 1/8 in; 4.445 cm x 6.985 cm x 7.9375 cm
overall: 3 in x 2 1/8 in x 2 1/8 in; 7.62 cm x 5.3975 cm x 5.3975 cm
place made
United States: California, South San Francisco
See more items in
Medicine and Science: Medicine
Health & Medicine
The Antibody Initiative
Antibody Initiative: Monoclonal Antibodies
Data Source
National Museum of American History
Subject
Women's Health
Link to Original Record
Record ID
nmah_1445190